• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Logo
  • Home
  • Understanding KCNT1
  • Parents & Caregivers
    • Newly Diagnosed
    • Early-Onset KCNT1 Epilepsies
      • Medications for Early-Onset Epilepsies
    • Sleep-Related Hypermotor Epilepsy (SHE)
    • Symptoms & Treatments Overview
    • Treatment Approaches
    • Genetics 101
    • Life Expectancy & Long-Term Planning  
    • Financial & Caregiving Tools
    • Support & Resources
    • Sign Up for Our Parent Contact Form
    • Share Your KCNT1 Story
    • Find a Doctor
    • World Map (Census)
  • Professionals
    • Clinicians
    • Industry
    • Researchers
      • Biospecimens
      • KCNT1 Funding
      • Publications
  • Research & Clinical Trials
    • Parents & Caregivers
    • Clinical Trials
    • Clinical Trial Educational Resources
  • Support Us
    • Get Involved
    • Ways to Give
      • Shop our Store
      • Host a Fundraiser
  • About Us
    • Our Mission
    • Our Team
    • Our Advisors
    • Our Approach
    • Our Partners
    • Our Families
  • News & Events
    • FDA Patient Session
    • KCNT1 Remembering Day: October 21
    • News
    • Newsletter
    • KCNT1 in Orlando
    • Past Conferences
      • KCNT1 Anaheim Family Conf
      • Million Dollar Bike Ride
  • Contact
  • D♡nate

KCNT1 Epilepsy Types: Deep Dive

KCNT1 Epilepsy Types: Deep Dive

EIMFS / MMPSI (Epilepsy of Infancy with Migrating Focal Seizures)

Onset: Usually before 6 months, sometimes within the first few weeks of life.
Seizures: Focal seizures that “migrate” between brain regions, often unnoticed at first.

  • Signs: facial twitching, eye deviation, hiccups, color changes, brief apnea
  • Rapid escalation to high-frequency, medication-resistant seizures

EEG Findings: Migration pattern across hemispheres

Development: Profound developmental delay is common due to the early and severe
seizure burden

Common Comorbidities: Feeding difficulties, sleep disruption, increased risk for
infections

Management:

  • Early ketogenic diet may help reduce seizures
  • Multiple AEDs may be trialed, often with limited success
  • Close respiratory and nutritional monitoring is essential

Infantile Spasms (IS)

Onset: Typically 3–7 months of age

Seizure Pattern: Clusters of sudden, brief body jerks—often mistaken for startle reflexes

  • Can include head drops, arm flinging, or stiffening
  • Often occur upon waking or falling asleep

EEG Findings: Classic “hypsarrhythmia”—a chaotic, high-amplitude pattern

Developmental Concerns:

  • Associated with sudden regression in developmental milestones
  • Delay in treatment can worsen long-term cognitive outcomes

KCNT1 Link:

  • Some children with KCNT1 mutations present first with Infantile Spasms
  • May evolve into EIMFS or other DEEs

Treatment Options:

  • First-line treatments include ACTH or vigabatrin
  • Early recognition and treatment can reduce risk of further regression

Early-Onset Epileptic Encephalopathy (EOEE) 

 

  • – Seizure Types: Tonic seizures, spasms, myoclonic movements, or generalized seizures 
  • – EEG: Diffuse slowing, suppression burst patterns, or multifocal spikes 
  • Seizures may be briefly controlled but often become intractable 
  • Developmental regression is frequent following seizure onset 
  • This category is often used early in diagnosis, before a more specific syndrome is identified 

ADSHE / ADSHE (Autosomal Dominant Sleep-Related Hypermotor Epilepsy)

Onset: Often between ages 2–12

Seizures: Violent, brief episodes during sleep

  • Movements may include flailing, sudden posturing, vocal outbursts
  • Often misdiagnosed as night terrors or parasomnias

Diagnosis:

  • Often requires overnight EEG or video-EEG
  • Daytime tests may miss nocturnal seizure activity

Genetics:

  • Many inherited from a parent with mild or no symptoms
  • May appear without known family history

Impact:

  • Sleep disruption can affect attention, behavior, learning
  • Ongoing seizures may lead to gradual cognitive decline

Treatment:

  • Some response to carbamazepine, oxcarbazepine, or lamotrigine
  • Behavioral and educational supports often needed

Footer

fluid-image
Donate Today
  • Parents & Caregivers
  • Researchers & Professionals
  • About Us
  • Contact
  • Subscribe
Gold 2025 Candid Seal
GAA Member Badge
Citizen Health Proud Partner 2025 Website Badge

Privacy Policy

© 2023 KCNT1 Epilepsy Foundation | All Rights Reserved | Disclaimer

EIN 84-2748218

Copyright © 2026